藥物掩味技術市場規模、佔有率和成長分析：按技術、劑型、應用、最終用戶和地區分類 - 產業預測，2026-2033年

2024 年全球藥品掩味技術市場價值為 29.1 億美元，預計到 2025 年將成長至 31.6 億美元，到 2033 年將成長至 61.2 億美元，在預測期（2026-2033 年）內複合年成長率為 8.6%。

全球藥物掩味技術市場正經歷顯著成長，尤其受到兒童和老年人群體對提高用藥依從性需求的日益成長的推動。該領域涵蓋包衣系統、微膠囊化和掩味輔料，正發展成為一個高盈利市場，這得益於慢性病患病率的上升以及口服液和咀嚼片製劑的普及。人工智慧驅動的自動化等創新正在變革製劑流程，提高預測準確性並簡化生產。自動化系統和雲端技術能夠實現快速迭代檢驗和即時監測掩味效果，最終降低成本並縮短產品上市時間。這種透過更美味的藥物來提高患者依從性的決心正在推動產業投資，並促進市場的持續擴張。

全球製藥味掩蔽技術市場的成長要素

人們越來越偏好選擇易於吞嚥的藥物，這推動了味覺掩蔽技術的應用，尤其是在兒童和老年人等弱勢群體中。當令人不快的味道被有效掩蓋時，患者更有可能堅持治療，從而提高藥物順從性。這種感官體驗的整體改善不僅能最大限度地降低治療中斷的風險，還能提升製造商的品牌聲譽，並擴大其在各個治療領域的市場吸引力。此外，這一趨勢正在推動對創新掩蔽解決方案和以患者依從性為優先的綜合製劑方法的投資，這反映了藥物設計理念的重大轉變。

全球藥物掩味技術市場的限制因素

全球藥品掩味技術市場面臨許多限制因素，主要源自於先進掩味解決方案的複雜性和高成本。開發這些技術通常需要大量投資於研發、專用設備和廣泛的檢驗流程。企業必須投入大量資源來提高掩味劑的有效性，確保其與活性成分的相容性，並遵守嚴格的安全性和有效性法規。這些財務負擔可能會阻礙小型製造商進入市場，尤其是在價格敏感的市場環境中，並抑制創新，最終限制整體市場成長和新型掩味配方的推出。因此，企業往往優先考慮傳統配方，這可能會限制市場多元化。

全球藥物掩味技術市場趨勢

全球藥品掩味技術市場正呈現以患者為中心的口味創新趨勢。製造商致力於透過引入先進的掩味技術來改善患者體驗，這些技術能夠模擬患者熟悉的味道，尤其對兒童和老年人有益。各公司正與感官科學家合作，利用天然甜味劑和創新的包封技術，打造符合文化偏好的客製化口味。這種綜合方法不僅有助於產品差異化，還能增強品牌忠誠度。消費者越來越傾向將更佳的偏好與更佳的治療效果連結起來，進而提升各種治療方案的整體醫療滿意度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球藥物掩味技術市場規模：依技術分類

• 塗層技術
• 封裝技術
• 離子交換樹脂技術
• 熱熔擠出成型
• 錯合的形成
• 其他

全球藥物掩味技術市場規模：以劑型分類

• 藥片
• 膠囊
• 粉末/顆粒
• 口服液體藥物

全球藥物掩味技術市場規模：按應用領域分類

• 兒童配方
• 為老年人做好準備
• 營養補充品
• 動物用藥品

全球藥品掩味技術市場規模：依最終用戶分類

• 製藥公司
• 合約研發生產組織（CDMO）
• 研究機構

全球藥用掩味技術市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Catalent, Inc.
• Lonza Group AG
• Evonik Industries AG
• Roquette Freres
• Colorcon, Inc.
• Ashland Inc.
• Kerry Group plc
• SPI Pharma, Inc.
• BASF SE
• Gattefosse SAS
• DFE Pharma GmbH & Co. KG
• Sensient Technologies Corporation
• CordenPharma International GmbH
• Adare Pharma Solutions
• Fuji Chemical Industry Co., Ltd.
• AptarGroup, Inc.
• IFF Pharma Solutions
• Gangwal Healthcare Pvt. Ltd.
• JRS Pharma GmbH & Co. KG
• Corel Pharma Chem

結論與建議

Global Drug Taste Masking Technologies Market size was valued at USD 2.91 Billion in 2024 and is poised to grow from USD 3.16 Billion in 2025 to USD 6.12 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The global drug taste-masking technologies market is experiencing significant growth due to increasing demand for patient compliance, particularly among pediatric and geriatric demographics. This sector, which includes coating systems, microencapsulation, and flavor-masking excipients, has evolved into a lucrative market fueled by the rising prevalence of chronic diseases and a shift toward oral liquid and chewable forms. Innovations such as AI-driven automation are transforming formulation processes, enhancing predictive accuracy, and streamlining production. Automated systems and cloud technology facilitate rapid iteration and real-time monitoring of taste-masking effectiveness, ultimately lowering costs and accelerating time-to-market. This focus on improving patient adherence through more palatable medications is fostering industry investment and contributing to sustained market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Taste Masking Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Taste Masking Technologies Market Segments Analysis

Global drug taste masking technologies market is segmented by technology, dosage form, application, end user and region. Based on technology, the market is segmented into Coating Technologies, Encapsulation Technologies, Ion Exchange Resin Technologies, Hot Melt Extrusion, Inclusion Complexation and Other Technologies. Based on dosage form, the market is segmented into Tablets, Capsules, Powders & Granules and Oral Liquids. Based on application, the market is segmented into Pediatric Formulations, Geriatric Formulations, Nutraceuticals and Veterinary Pharmaceuticals. Based on end user, the market is segmented into Pharmaceutical Companies, Contract Development & Manufacturing Organizations and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Taste Masking Technologies Market

The increasing preference for medications that are easier to swallow propels the use of taste-masking technologies, particularly among vulnerable populations like children and the elderly. When unpleasant flavors are effectively masked, patients are more inclined to follow their prescribed treatments, leading to improved adherence. This enhancement of the overall sensory experience not only minimizes the risk of therapy discontinuation but also boosts the manufacturer's brand reputation and broadens their market appeal across various therapeutic sectors. Additionally, this trend encourages investment in innovative masking solutions and comprehensive formulation approaches that prioritize patient compliance, reflecting a significant shift in drug design philosophy.

Restraints in the Global Drug Taste Masking Technologies Market

The Global Drug Taste Masking Technologies market faces several restraints primarily due to the complexity and costs associated with advanced taste-masking solutions. The development of these technologies often necessitates considerable investment in research, specialized equipment, and extensive validation processes. Companies must devote substantial resources to enhance the effectiveness of masking agents, ensure their compatibility with active pharmaceutical ingredients, and comply with rigorous safety and efficacy regulations. These financial burdens can dissuade smaller manufacturers from entering the market and hinder innovation, particularly in price-sensitive environments, thereby impeding overall market growth and the introduction of new taste-masked formulations. Consequently, organizations may favor traditional formulations, limiting the diversification of the market.

Market Trends of the Global Drug Taste Masking Technologies Market

The Global Drug Taste Masking Technologies market is witnessing a significant trend towards patient-centric flavor innovation. Manufacturers are focusing on enhancing the patient experience by implementing advanced flavor-masking technologies that replicate familiar tastes, which is particularly beneficial for pediatric and geriatric populations. By collaborating with sensory scientists, companies are able to create customized taste profiles that resonate with cultural preferences, utilizing natural sweeteners and innovative encapsulation techniques. This comprehensive approach not only enhances product differentiation but also fosters brand loyalty, as consumers increasingly link improved palatability with better therapeutic outcomes, thereby elevating overall healthcare satisfaction across varied treatment regimens.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Drug Taste Masking Technologies Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Coating Technologies
• Encapsulation Technologies
• Ion Exchange Resin Technologies
• Hot Melt Extrusion
• Inclusion Complexation
• Other Technologies

Global Drug Taste Masking Technologies Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets
• Capsules
• Powders & Granules
• Oral Liquids

Global Drug Taste Masking Technologies Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pediatric Formulations
• Geriatric Formulations
• Nutraceuticals
• Veterinary Pharmaceuticals

Global Drug Taste Masking Technologies Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Contract Development & Manufacturing Organizations
• Research Institutes

Global Drug Taste Masking Technologies Market Size & CAGR (2026-2033)

• North America (Technology, Dosage Form, Application, End User)
  • US
  • Canada
• Europe (Technology, Dosage Form, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Dosage Form, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Dosage Form, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Dosage Form, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Catalent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensient Technologies Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CordenPharma International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adare Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industry Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IFF Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gangwal Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JRS Pharma GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corel Pharma Chem
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations